VapoTherm misses in Q3, lowers guidance

VapoTherm (NYSE:VAPO) shares fell this morning on third-quarter results that came up short of the consensus forecast.

The Exeter, New Hampshire-based company posted losses of $91.8 million. That equals 98¢ per share on sales of $13.55 million for the three months ended Sept. 30, 2022.

VapoTherm registered a massive bottom-line slide deeper into the red on a sales decline of 64.5%. The company attributed year-over-year revenue declines as the Delta variant of COVID-19 drove demand for the company’s products this time last year. That failed to repeat in the three-month period this year.

The company’s losses per share of 98¢ came in 20¢ behind expectations on Wall Street. Analysts projected revenues of $13.54 million.

“Our revenue increased sequentially from the second quarter to the third quarter which is not typical given the seasonality in our business,” VapoTherm President and CEO Joseph Army said in a news release. “Growth was driven…

Read more
  • 0

How medtech is tackling supply chain challenges

A host of medical device companies with manufacturing in Puerto Rico found their supply chains impacted by Hurricane Maria in 2017. It was a harbinger of what was to come. [Image is public domain]Join us at DeviceTalks Boston on May 10-11 to hear how medical device companies are propping open supply lines and ensuring a steady flow of products to customers in a constantly changing world.

Sharing best practices is more important than ever because supply chain challenges aren’t expected to diminish post-pandemic. That’s because superstorms, fires, droughts and other extreme events driven by climate change are already straining the industry’s supply chain — and it could get a lot worse.

(Go to DeviceTalks Boston’s site to register!) 

Over the two-day meeting we’ll hear how companies large and small are adapting to new demands, including:

How Viant and Vapotherm combined forces to meet unforeseen demands brought on by the COVID-19 pandemi…
Read more
  • 0

Vapotherm announces executive leadership changes

Vapotherm this week announced that it has appointed Brian Lawrence as senior VP and chief technology officer and Dorota McKay as controller and chief accounting officer, effective immediately.

Prior to joining the company, Lawrence was chief technology officer and general manager of Gravity Diagnostics where he was responsible for technology and innovation programs across the company, according to an SEC filing. He has also held numerous leadership roles at Hillrom and GE Healthcare.

McKay most recently served as controller of Decibel Therapeutics. She has also held financial leadership roles at Oxford Immunotec Global, Altra Industrial Motion and Macpage.

Read more
  • 0